Siren Biotechnology, Inc

CIK: 2020584DEIncorporated: 2020-09-14

Current Offering

$49,996
Target Amount
$4,999,995
Maximum Amount
2026-04-30
Deadline

Security Details

Type: Preferred Stock
Price per share: $6.41
Shares offered: 7,800+

Offering Costs

Cash commission: 5%
5.0% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
Equity compensation: 0%
No

Financial Reports

Offering via Wefunder

Offering History

As of 2025-04-02
Raising $49,996 -$4,999,995 via 7,800+ shares of preferred Stock at $6.41 per share
Deadline: 2026-04-30
Filing date2025-04-02
Current employees6
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$17,448,263
Cash equi prior fiscal year$2,581,976
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$0.00
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$4,666,672.00
Net income prior fiscal year-$3,659,223.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$784,882
Short term debt prior fiscal year$117,038
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$17,539,808
Total asset prior fiscal year$2,741,295

Company Information

Corporation
DE
2020-09-14

Latest Metrics

Employees6
Total Assets$17,539,808
Cash on Hand$17,448,263
Revenues$0.00
Net Income-$4,666,672.00

Crowdfunding Portals

This company is raising funds through this portal